Pharmosa Biopharm Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	136.72	167.57	314.5	-	-	-
Revenue Growth (YoY)	170.62%	-46.72%	-	-	-	-
Cost of Revenue	19.8	40.67	-	-	-	-
Gross Profit	116.92	126.9	314.5	-	-	-
Selling, General & Admin	48.06	50.69	40.35	29.22	18.32	12.11
Research & Development	325.94	294.79	276.97	242.31	240.81	175.31
Operating Expenses	374	345.47	317.32	271.53	259.12	187.42
Operating Income	-257.08	-218.57	-2.82	-271.53	-259.12	-187.42
Interest Expense	-2.18	-2.42	-2.86	-0.65	-1.21	-3.86
Interest & Investment Income	33.63	32.07	9.53	0.5	0.1	0.04
Earnings From Equity Investments	-0.28	1.95	5.5	3.93	0.66	4.63
Currency Exchange Gain (Loss)	-11.87	19.31	-6.68	1.02	0.2	0.96
Other Non Operating Income (Expenses)	0.03	1.16	5.79	0.23	2.89	3.96
EBT Excluding Unusual Items	-237.74	-166.49	8.46	-266.51	-256.48	-181.7
Gain (Loss) on Sale of Assets	-	-0.34	-	-	-	-
Other Unusual Items	-	0.18	-	-	-	-
Pretax Income	-237.74	-166.65	8.46	-266.51	-256.48	-181.7
Net Income	-237.74	-166.65	8.46	-266.51	-256.48	-181.7
Net Income to Common	-237.74	-166.65	8.46	-266.51	-256.48	-181.7
Shares Outstanding (Basic)	129	126	113	99	85	48
Shares Outstanding (Diluted)	129	126	113	99	85	48
Shares Change (YoY)	4.56%	11.49%	15.09%	16.02%	78.34%	27.94%
EPS (Basic)	-1.84	-1.32	0.07	-2.70	-3.02	-3.82
EPS (Diluted)	-1.85	-1.32	0.07	-2.70	-3.02	-3.82
Free Cash Flow	-379.76	-292.43	-50.01	-268.47	-240.57	-188.5
Free Cash Flow Per Share	-2.94	-2.31	-0.44	-2.73	-2.83	-3.96
Gross Margin	85.52%	75.73%	100.00%	-	-	-
Operating Margin	-188.03%	-130.44%	-0.90%	-	-	-
Profit Margin	-173.89%	-99.45%	2.69%	-	-	-
Free Cash Flow Margin	-277.76%	-174.51%	-15.90%	-	-	-
EBITDA	-237.26	-205.09	2.99	-266.24	-254.73	-184.2
EBITDA Margin	-173.53%	-122.39%	0.95%	-	-	-
D&A For EBITDA	19.82	13.48	5.81	5.3	4.39	3.22
EBIT	-257.08	-218.57	-2.82	-271.53	-259.12	-187.42
EBIT Margin	-188.03%	-130.44%	-0.90%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.